(Q51709478)

10 April 2018

title

Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. (English)

1 reference

10 April 2018

main subject

anti-retroviral agent

0 references

0 references

3

G Chêne

1 reference

10 April 2018

François Dabis

10

object named as

F Dabis

1 reference

10 April 2018

author name string

F Bonnet

1

1 reference

10 April 2018

P Morlat

2

1 reference

10 April 2018

P Mercié

4

1 reference

10 April 2018

D Neau

5

1 reference

10 April 2018

I Chossat

6

1 reference

10 April 2018

M Decoin

7

1 reference

10 April 2018

F Djossou

8

1 reference

10 April 2018

J Beylot

9

1 reference

10 April 2018

Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)

11

1 reference

10 April 2018

publication date

1 July 2002

1 reference

10 April 2018

published in

HIV Medicine

1 reference

10 April 2018

volume

3

1 reference

10 April 2018

issue

3

1 reference

10 April 2018

page(s)

195-199

1 reference

10 April 2018

Causes of death in persons with human immunodeficiency virus infection

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00117.X

Causes of death of HIV-infected persons in Ottawa, Ontario, 1984-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00117.X

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00117.X

Impact of HAART on causes of death of persons with late-stage AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00117.X

Pre-AIDS mortality in HIV-infected individuals in England, Wales and Northern Ireland, 1982-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00117.X

HIV-associated respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00117.X

Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00117.X

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00117.X

Natural history of HIV infection in the era of combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00117.X

Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00117.X

Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00117.X

Increase of atherogenic plasma profile in HIV-infected patients treated with protease inhibitor-containing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00117.X

10.1046/J.1468-1293.2002.00117.X

21 January 2018

Identifiers

DOI

1 reference

10 April 2018

1 reference

10 April 2018